We want your views on Australia’s growing ribonucleic acid (RNA) sector.
RNA shot to prominence during the COVID-19 pandemic, with the highly effective Moderna and Pfizer vaccines helping save lives. But RNA still has more potential as a vaccine or therapeutic to combat other diseases.
We’re seeking stakeholder views about what is working well within Australia’s RNA sector, and what could be improved.
Your feedback will:
- give us insights into Australia’s RNA sector capabilities and priorities for the next 10 years
- help us understand the challenges and opportunities for the RNA sector in Australia.